Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-12-08 Sale | 2025-12-10 4:32 pm | COLLEGIUM PHARMACEUTICAL INC | COLL | Dreyer Scott EVP & Chief Commercial Officer | 17,600 | $48.17 | $847,855 | 103,613 (Direct) | View |
| 2025-12-05 Sale | 2025-12-09 4:22 pm | COLLEGIUM PHARMACEUTICAL INC | COLL | Balice-Gordon Rita J. Director | 3,650 | $47.03 | $171,673 | 52,629 (Direct) | View |
| 2025-11-12 Sale | 2025-11-14 4:10 pm | COLLEGIUM PHARMACEUTICAL INC | COLL | Fallon John A. Director | 34,853 | $47.21 | $1,645,536 | 64,634 (Direct) | View |
| 2025-11-06 Sale | 2025-11-07 4:23 pm | COLLEGIUM PHARMACEUTICAL INC | COLL | Tupper Colleen EVP & Chief Financial Officer | 30,000 | $40.53 | $1,215,753 | 126,667 (Direct) | View |
| 2025-08-29 Sale | 2025-09-03 4:56 pm | COLLEGIUM PHARMACEUTICAL INC | COLL | Smith Thomas B EVP and Chief Medical Officer | 17,478 | $38.42 | $671,576 | 70,264 (Direct) | View |
| 2025-08-18 Sale | 2025-08-20 4:57 pm | COLLEGIUM PHARMACEUTICAL INC | COLL | Dreyer Scott EVP & Chief Commercial Officer | 16,389 | $38.21 | $626,171 | 103,613 (Direct) | View |
| 2025-08-15 Sale | 2025-08-19 5:10 pm | COLLEGIUM PHARMACEUTICAL INC | COLL | SANTINI GINO Director | 5,405 | $37.19 | $201,018 | 95,042 (Direct) | View |
| 2025-08-13 Sale | 2025-08-15 5:08 pm | COLLEGIUM PHARMACEUTICAL INC | COLL | Dreyer Scott EVP & Chief Commercial Officer | 4,861 | $38.03 | $184,881 | 120,002 (Direct) | View |
| 2025-08-13 Sale | 2025-08-15 4:12 pm | COLLEGIUM PHARMACEUTICAL INC | COLL | Rubric Capital Management LP Rosen David Efraim 10% Owner | 25,000 | $37.85 | $946,250 | 3,132,743 (Indirect) | View |
| 2025-08-08 Sale | 2025-08-12 5:18 pm | COLLEGIUM PHARMACEUTICAL INC | COLL | Freund John Gordon Director | 11,659 | $34.36 | $400,641 | 102,412 (Indirect Direct) | View |
| 2025-06-09 Sale | 2025-06-11 5:04 pm | COLLEGIUM PHARMACEUTICAL INC | COLL | Freund John Gordon Director | 6,601 | $30.62 | $202,149 | 114,071 (Indirect Direct) | View |
| 2025-03-20 Sale | 2025-03-24 5:06 pm | COLLEGIUM PHARMACEUTICAL INC | COLL | Tupper Colleen EVP & Chief Financial Officer | 7,602 | $30.02 | $228,250 | 156,667 (Direct) | View |
| 2025-03-20 Sale | 2025-03-24 5:05 pm | COLLEGIUM PHARMACEUTICAL INC | COLL | Dreyer Scott EVP & Chief Commercial Officer | 20,808 | $30.03 | $624,794 | 103,613 (Direct) | View |
| 2025-03-11 Sale(A) | 2025-03-18 7:18 pm | COLLEGIUM PHARMACEUTICAL INC | COLL | Dreyer Scott EVP & Chief Commercial Officer | 15,387 | $30 | $461,672 | 126,676 (Direct) | View |
| 2025-03-14 Sale | 2025-03-18 5:35 pm | COLLEGIUM PHARMACEUTICAL INC | COLL | Tupper Colleen EVP & Chief Financial Officer | 977 | $30 | $29,313 | 164,269 (Direct) | View |
| 2025-03-14 Sale | 2025-03-18 5:34 pm | COLLEGIUM PHARMACEUTICAL INC | COLL | Dreyer Scott EVP & Chief Commercial Officer | 2,255 | $30 | $67,661 | 124,421 (Direct) | View |
| 2025-03-06 Sale | 2025-03-13 4:50 pm | COLLEGIUM PHARMACEUTICAL INC | COLL | Dreyer Scott EVP & Chief Commercial Officer | 15,387 | $30 | $461,672 | 126,676 (Direct) | View |
| 2025-03-11 Sale | 2025-03-13 4:49 pm | COLLEGIUM PHARMACEUTICAL INC | COLL | Tupper Colleen EVP & Chief Financial Officer | 10,445 | $30.01 | $313,413 | 165,246 (Direct) | View |
| 2025-03-06 Sale | 2025-03-10 4:02 pm | COLLEGIUM PHARMACEUTICAL INC | COLL | Tupper Colleen EVP & Chief Financial Officer | 3,453 | $30 | $103,591 | 175,691 (Direct) | View |
| 2025-03-06 Sale | 2025-03-10 4:01 pm | COLLEGIUM PHARMACEUTICAL INC | COLL | Dreyer Scott EVP & Chief Commercial Officer | 5,643 | $30 | $169,299 | 142,063 (Direct) | View |
| 2025-03-04 Sale | 2025-03-06 6:48 pm | COLLEGIUM PHARMACEUTICAL INC | COLL | Kuhlmann Shirley R. EVP and General Counsel | 86,067 | $28.19 | $2,426,634 | 108,137 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-02-10 Option Award | 2026-02-12 4:30 pm | N/A N/A | COLLEGIUM PHARMACEUTICAL INC | COLL | Dieter David EVP & General Counsel | 31,199 | $0 | 97,271 (Direct) | View |
| 2026-02-10 Tax Withholding | 2026-02-12 4:30 pm | N/A N/A | COLLEGIUM PHARMACEUTICAL INC | COLL | Dieter David EVP & General Counsel | 2,781 | $46.75 | 97,271 (Direct) | View |
| 2026-02-10 Option Award | 2026-02-12 4:30 pm | N/A N/A | COLLEGIUM PHARMACEUTICAL INC | COLL | Karnani Vikram President and CEO | 111,795 | $0 | 197,864 (Direct) | View |
| 2026-02-10 Tax Withholding | 2026-02-12 4:30 pm | N/A N/A | COLLEGIUM PHARMACEUTICAL INC | COLL | Karnani Vikram President and CEO | 11,296 | $46.75 | 197,864 (Direct) | View |
| 2026-02-10 Option Award | 2026-02-12 4:30 pm | N/A N/A | COLLEGIUM PHARMACEUTICAL INC | COLL | Smith Thomas B EVP and Chief Medical Officer | 37,042 | $0 | 90,651 (Direct) | View |
| 2026-02-10 Tax Withholding | 2026-02-12 4:30 pm | N/A N/A | COLLEGIUM PHARMACEUTICAL INC | COLL | Smith Thomas B EVP and Chief Medical Officer | 17,435 | $46.75 | 90,651 (Direct) | View |
| 2026-02-10 Option Award | 2026-02-12 4:30 pm | N/A N/A | COLLEGIUM PHARMACEUTICAL INC | COLL | Tupper Colleen EVP & Chief Financial Officer | 59,155 | $0 | 147,282 (Direct) | View |
| 2026-02-10 Tax Withholding | 2026-02-12 4:30 pm | N/A N/A | COLLEGIUM PHARMACEUTICAL INC | COLL | Tupper Colleen EVP & Chief Financial Officer | 38,540 | $46.75 | 147,282 (Direct) | View |
| 2026-02-10 Option Award | 2026-02-12 4:30 pm | N/A N/A | COLLEGIUM PHARMACEUTICAL INC | COLL | Dreyer Scott EVP & Chief Commercial Officer | 49,725 | $0 | 121,746 (Direct) | View |
| 2026-02-10 Tax Withholding | 2026-02-12 4:30 pm | N/A N/A | COLLEGIUM PHARMACEUTICAL INC | COLL | Dreyer Scott EVP & Chief Commercial Officer | 31,592 | $46.75 | 121,746 (Direct) | View |
| 2025-12-08 Exercise | 2025-12-10 4:32 pm | N/A 2029-01-25 | COLLEGIUM PHARMACEUTICAL INC | COLL | Dreyer Scott EVP & Chief Commercial Officer | 17,600 | $0 | 103,613 (Direct) | View |
| 2025-12-08 Exercise | 2025-12-10 4:32 pm | N/A N/A | COLLEGIUM PHARMACEUTICAL INC | COLL | Dreyer Scott EVP & Chief Commercial Officer | 17,600 | $15.9 | 103,613 (Direct) | View |
| 2025-11-12 Tax Withholding | 2025-11-14 4:13 pm | N/A N/A | COLLEGIUM PHARMACEUTICAL INC | COLL | Karnani Vikram President and CEO | 8,983 | $47.35 | 96,989 (Direct) | View |
| 2025-11-12 Exercise | 2025-11-14 4:10 pm | N/A N/A | COLLEGIUM PHARMACEUTICAL INC | COLL | Fallon John A. Director | 15,000 | $16.49 | 64,634 (Direct) | View |
| 2025-11-12 Exercise | 2025-11-14 4:10 pm | N/A N/A | COLLEGIUM PHARMACEUTICAL INC | COLL | Fallon John A. Director | 19,853 | $9.33 | 64,634 (Direct) | View |
| 2025-11-12 Exercise | 2025-11-14 4:10 pm | N/A 2026-06-09 | COLLEGIUM PHARMACEUTICAL INC | COLL | Fallon John A. Director | 34,853 | $0 | 64,634 (Direct) | View |
| 2025-08-18 Exercise | 2025-08-20 4:57 pm | N/A N/A | COLLEGIUM PHARMACEUTICAL INC | COLL | Dreyer Scott EVP & Chief Commercial Officer | 16,389 | $21.34 | 103,613 (Direct) | View |
| 2025-08-18 Exercise | 2025-08-20 4:57 pm | N/A 2030-02-05 | COLLEGIUM PHARMACEUTICAL INC | COLL | Dreyer Scott EVP & Chief Commercial Officer | 16,389 | $0 | 103,613 (Direct) | View |
| 2025-08-15 Exercise | 2025-08-19 5:10 pm | N/A 2025-09-10 | COLLEGIUM PHARMACEUTICAL INC | COLL | SANTINI GINO Director | 15,000 | $0 | 95,042 (Direct) | View |
| 2025-08-15 Exercise | 2025-08-19 5:10 pm | N/A N/A | COLLEGIUM PHARMACEUTICAL INC | COLL | SANTINI GINO Director | 15,000 | $13.45 | 95,042 (Direct) | View |
| 2025-08-13 Exercise | 2025-08-15 5:08 pm | N/A N/A | COLLEGIUM PHARMACEUTICAL INC | COLL | Dreyer Scott EVP & Chief Commercial Officer | 4,861 | $21.34 | 120,002 (Direct) | View |
| 2025-08-13 Exercise | 2025-08-15 5:08 pm | N/A 2030-02-05 | COLLEGIUM PHARMACEUTICAL INC | COLL | Dreyer Scott EVP & Chief Commercial Officer | 4,861 | $0 | 120,002 (Direct) | View |
Ownership | 2025-08-15 4:10 pm | N/A N/A | COLLEGIUM PHARMACEUTICAL INC | COLL | Rubric Capital Management LP Rosen David Efraim 10% Owner | 0 | $0 | 3,157,743 (Indirect) | View |
| 2025-06-09 Exercise | 2025-06-11 5:04 pm | N/A 2025-09-10 | COLLEGIUM PHARMACEUTICAL INC | COLL | Freund John Gordon Director | 15,000 | $0 | 114,071 (Direct) | View |
| 2025-06-09 Exercise | 2025-06-11 5:04 pm | N/A N/A | COLLEGIUM PHARMACEUTICAL INC | COLL | Freund John Gordon Director | 15,000 | $13.45 | 114,071 (Direct) | View |
| 2025-05-15 Option Award | 2025-05-19 5:43 pm | N/A N/A | COLLEGIUM PHARMACEUTICAL INC | COLL | Fallon John A. Director | 9,791 | $0 | 64,634 (Direct) | View |
| 2025-05-15 Option Award | 2025-05-19 5:43 pm | N/A N/A | COLLEGIUM PHARMACEUTICAL INC | COLL | Lurker Nancy Director | 9,791 | $0 | 22,517 (Direct) | View |
| 2025-05-15 Option Award | 2025-05-19 5:42 pm | N/A N/A | COLLEGIUM PHARMACEUTICAL INC | COLL | BOHLIN GAREN G Director | 9,791 | $0 | 62,259 (Direct) | View |
| 2025-05-15 Option Award | 2025-05-19 5:42 pm | N/A N/A | COLLEGIUM PHARMACEUTICAL INC | COLL | Balice-Gordon Rita J. Director | 9,791 | $0 | 56,279 (Direct) | View |
| 2025-05-15 Option Award | 2025-05-19 5:42 pm | N/A N/A | COLLEGIUM PHARMACEUTICAL INC | COLL | Freund John Gordon Director | 9,791 | $0 | 105,672 (Direct) | View |
| 2025-05-15 Option Award | 2025-05-19 5:39 pm | N/A N/A | COLLEGIUM PHARMACEUTICAL INC | COLL | SANTINI GINO Director | 9,791 | $0 | 85,447 (Direct) | View |
| 2025-05-15 Option Award | 2025-05-19 5:37 pm | N/A N/A | COLLEGIUM PHARMACEUTICAL INC | COLL | Paya Carlos V Director | 19,582 | $0 | 19,582 (Direct) | View |
| 2025-03-17 Option Award | 2025-03-19 4:36 pm | N/A N/A | COLLEGIUM PHARMACEUTICAL INC | COLL | Dieter David EVP & General Counsel | 68,449 | $0 | 68,449 (Direct) | View |
| 2025-03-04 Exercise | 2025-03-06 6:48 pm | N/A N/A | COLLEGIUM PHARMACEUTICAL INC | COLL | Kuhlmann Shirley R. EVP and General Counsel | 40,000 | $24.03 | 108,137 (Direct) | View |
| 2025-03-04 Exercise | 2025-03-06 6:48 pm | N/A 2028-04-04 | COLLEGIUM PHARMACEUTICAL INC | COLL | Kuhlmann Shirley R. EVP and General Counsel | 40,000 | $0 | 108,137 (Direct) | View |
| 2025-02-10 Option Award | 2025-02-12 4:10 pm | N/A N/A | COLLEGIUM PHARMACEUTICAL INC | COLL | Heffernan Michael Thomas Director | 4,820 | $0 | 50,328 (Direct) | View |
| 2025-02-10 Tax Withholding | 2025-02-12 4:10 pm | N/A N/A | COLLEGIUM PHARMACEUTICAL INC | COLL | Smith Thomas B EVP and Chief Medical Officer | 5,897 | $30.52 | 87,742 (Direct) | View |
| 2025-02-10 Option Award | 2025-02-12 4:10 pm | N/A N/A | COLLEGIUM PHARMACEUTICAL INC | COLL | Smith Thomas B EVP and Chief Medical Officer | 39,075 | $0 | 87,742 (Direct) | View |